We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (MEMMAT)

This study is currently recruiting participants.
Verified May 2017 by Andreas Peyrl, Medical University of Vienna
Sponsor:
ClinicalTrials.gov Identifier:
NCT01356290
First Posted: May 19, 2011
Last Update Posted: May 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Andreas Peyrl, Medical University of Vienna
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2022
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)